Bank of America’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-149,118
Closed -$10.2M 8785
2022
Q3
$10.2M Sell
149,118
-195,044
-57% -$10.8M ﹤0.01% 2603
2022
Q2
$11M Sell
344,162
-1,473,025
-81% -$43.1M ﹤0.01% 2582
2022
Q1
$62.9M Buy
1,817,187
+260,871
+17% +$7.8M 0.01% 1208
2021
Q4
$45.6M Sell
1,556,316
-252,341
-14% -$7.82M ﹤0.01% 1465
2021
Q3
$46.1M Sell
1,808,657
-4,326,789
-71% -$127M 0.01% 1415
2021
Q2
$215M Sell
6,135,446
-67,623
-1% -$2.64M 0.02% 596
2021
Q1
$253M Buy
6,203,069
+136,842
+2% +$6.29M 0.03% 498
2020
Q4
$263M Buy
6,066,227
+478,589
+9% +$23.6M 0.04% 439
2020
Q3
$308M Buy
5,587,638
+104,388
+2% +$6.63M 0.04% 368
2020
Q2
$346M Buy
5,483,250
+152,436
+3% +$10.5M 0.06% 317
2020
Q1
$272M Buy
5,330,814
+617,828
+13% +$41.4M 0.05% 332
2019
Q4
$375M Buy
4,712,986
+1,156,164
+33% +$68.5M 0.06% 331
2019
Q3
$173M Buy
3,556,822
+285,545
+9% +$14.9M 0.03% 536
2019
Q2
$172M Buy
3,271,277
+392,104
+14% +$22.5M 0.03% 538
2019
Q1
$152M Buy
2,879,173
+336,012
+13% +$16.5M 0.03% 569
2018
Q4
$104M Buy
2,543,161
+1,094,742
+76% +$41M 0.02% 657
2018
Q3
$55M Buy
1,448,419
+1,317,585
+1,007% +$58.4M 0.01% 1046
2018
Q2
$5.92M Buy
130,834
+113,277
+645% +$5.16M ﹤0.01% 2988
2018
Q1
$849K Buy
17,557
+5,124
+41% +$286K ﹤0.01% 4498
2017
Q4
$489K Sell
12,433
-6,439
-34% -$240K ﹤0.01% 4959
2017
Q3
$586K Buy
18,872
+12,667
+204% +$356K ﹤0.01% 4870
2017
Q2
$170K Sell
6,205
-936
-13% -$27.9K ﹤0.01% 5382
2017
Q1
$263K Buy
7,141
+3,633
+104% +$91.5K ﹤0.01% 5196
2016
Q4
$51K Buy
3,508
+2,786
+386% +$48.9K ﹤0.01% 5918
2016
Q3
$17K Sell
722
-5,497
-88% -$105K ﹤0.01% 6199
2016
Q2
$103K Buy
6,219
+5,362
+626% +$108K ﹤0.01% 5513
2016
Q1
$14K Buy
857
+690
+413% +$12.3K ﹤0.01% 6284
2015
Q4
$5K Sell
167
-962
-85% -$41.7K ﹤0.01% 6893
2015
Q3
$48K Buy
+1,129
New +$53.3K ﹤0.01% 5965

Other funds holding GBT